Page last updated: 2024-08-17

indacrinone and Adverse Drug Event

indacrinone has been researched along with Adverse Drug Event in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Chanda, D; Darokar, MP; Dwivedi, GR; Kumar, A; Negi, AS; Pal, A; Roy, S; Sharma, A; Singh, A; Tiwari, N	1

Other Studies

2 other study(ies) available for indacrinone and Adverse Drug Event

Article	Year
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011
Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli. Applied microbiology and biotechnology, 2016, Volume: 100, Issue:5 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Escherichia coli; Gallic Acid; Indans; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Shock, Septic; Tetracycline	2016

Article

Year

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology, 2011, Volume: 7, Issue:12

Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011

Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.

Applied microbiology and biotechnology, 2016, Volume: 100, Issue:5

Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Escherichia coli; Gallic Acid; Indans; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Shock, Septic; Tetracycline

2016